← Back
$URGN All transactions

UroGen Pharma Ltd.

M

$ Value

$0

Shares

3,333

Price

$0

Filed

Sep 9

Insider

Name

Smith Jason Drew

Title

General Counsel

CIK

0001821479

Roles

Officer

Transaction Details

Transaction Date

2025-09-07

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

3,334

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. | Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. | The reporting person was granted RSUs on September 7, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024.

Filing Info

Accession No.

0001437749-25-028705

Form Type

4

Issuer CIK

0001668243

Smith Jason Drew's History

Date Ticker Type Value
2026-02-03 URGN $52K
2026-02-03 URGN $32K
2026-02-03 URGN $63K
2026-01-31 URGN M
2026-01-31 URGN M
2026-01-31 URGN M
2026-01-31 URGN M $0
2026-01-31 URGN M $0
2026-01-31 URGN M $0
2026-01-31 URGN A $0

Other Insiders at URGN (90d)

Insider Bought Sold Last
Robinson James A. Jr. 2025-02-26
Degnan Chris
Chief Financial Officer
2026-01-31
Schoenberg Mark
Chief Medical Officer
$145K 2026-02-03
Barrett Elizabeth A.
Chief Executive Officer
2026-01-31
Smith Jason Drew
General Counsel
$147K 2026-02-03